BrightGene Bio-Medical Technology Co Ltd
SSE:688166
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
BrightGene Bio-Medical Technology Co Ltd
SSE:688166
|
CN |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
US |
Cash Flow Statement
Cash Flow Statement
BrightGene Bio-Medical Technology Co Ltd
| Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||||||||
| Cash Taxes Paid |
(0)
|
(6)
|
(7)
|
(5)
|
2
|
4
|
10
|
10
|
7
|
8
|
7
|
2
|
16
|
29
|
17
|
13
|
(19)
|
(32)
|
(29)
|
(22)
|
(21)
|
(25)
|
(25)
|
(21)
|
(17)
|
(19)
|
|
| Change in Working Capital |
(266)
|
(192)
|
(209)
|
(230)
|
(222)
|
(207)
|
(228)
|
(233)
|
(282)
|
(350)
|
(348)
|
(391)
|
(391)
|
(401)
|
(440)
|
(464)
|
(458)
|
(480)
|
(433)
|
(404)
|
(474)
|
(474)
|
(535)
|
(531)
|
(550)
|
(599)
|
|
| Cash from Operating Activities |
67
N/A
|
41
-39%
|
61
+49%
|
70
+15%
|
117
+66%
|
144
+23%
|
155
+8%
|
164
+5%
|
109
-33%
|
149
+36%
|
176
+18%
|
143
-19%
|
207
+45%
|
299
+45%
|
311
+4%
|
366
+18%
|
319
-13%
|
204
-36%
|
195
-5%
|
318
+63%
|
294
-8%
|
216
-27%
|
246
+14%
|
204
-17%
|
208
+2%
|
225
+8%
|
|
| Investing Cash Flow | |||||||||||||||||||||||||||
| Capital Expenditures |
(152)
|
(62)
|
(90)
|
(108)
|
(149)
|
(194)
|
(355)
|
(602)
|
(765)
|
(914)
|
(910)
|
(964)
|
(872)
|
(833)
|
(727)
|
(541)
|
(480)
|
(389)
|
(404)
|
(366)
|
(371)
|
(354)
|
(257)
|
(360)
|
(393)
|
(370)
|
|
| Other Items |
(117)
|
(76)
|
(67)
|
4
|
(236)
|
(199)
|
(187)
|
(101)
|
71
|
5
|
20
|
(344)
|
(249)
|
(192)
|
(145)
|
74
|
(67)
|
(56)
|
(36)
|
27
|
(17)
|
(143)
|
(183)
|
(169)
|
(143)
|
(198)
|
|
| Cash from Investing Activities |
(269)
N/A
|
(138)
+49%
|
(156)
-13%
|
(105)
+33%
|
(384)
-267%
|
(393)
-2%
|
(542)
-38%
|
(703)
-30%
|
(695)
+1%
|
(909)
-31%
|
(890)
+2%
|
(1 307)
-47%
|
(1 121)
+14%
|
(1 024)
+9%
|
(872)
+15%
|
(467)
+46%
|
(547)
-17%
|
(445)
+19%
|
(440)
+1%
|
(339)
+23%
|
(388)
-15%
|
(497)
-28%
|
(440)
+11%
|
(529)
-20%
|
(536)
-1%
|
(568)
-6%
|
|
| Financing Cash Flow | |||||||||||||||||||||||||||
| Net Issuance of Debt |
0
|
0
|
0
|
5
|
45
|
132
|
220
|
473
|
499
|
680
|
671
|
1 087
|
1 226
|
990
|
1 172
|
502
|
348
|
373
|
118
|
141
|
242
|
(26)
|
15
|
(15)
|
(75)
|
111
|
|
| Cash Paid for Dividends |
0
|
0
|
(0)
|
0
|
(34)
|
(34)
|
(35)
|
(37)
|
(38)
|
(47)
|
(54)
|
(61)
|
(90)
|
(95)
|
(100)
|
(100)
|
(118)
|
(114)
|
(115)
|
(136)
|
(69)
|
(133)
|
(136)
|
(126)
|
(172)
|
(110)
|
|
| Other |
0
|
0
|
440
|
0
|
0
|
441
|
1
|
0
|
0
|
7
|
87
|
0
|
147
|
140
|
293
|
353
|
293
|
288
|
58
|
(9)
|
(20)
|
(20)
|
96
|
297
|
351
|
442
|
|
| Cash from Financing Activities |
0
N/A
|
0
N/A
|
440
N/A
|
445
+1%
|
451
+1%
|
539
+20%
|
186
-66%
|
437
+135%
|
463
+6%
|
639
+38%
|
704
+10%
|
1 112
+58%
|
1 282
+15%
|
1 034
-19%
|
1 365
+32%
|
756
-45%
|
523
-31%
|
548
+5%
|
62
-89%
|
(5)
N/A
|
153
N/A
|
(179)
N/A
|
(24)
+86%
|
156
N/A
|
104
-33%
|
443
+326%
|
|
| Change in Cash | |||||||||||||||||||||||||||
| Effect of Foreign Exchange Rates |
3
|
3
|
2
|
4
|
2
|
(4)
|
(13)
|
(9)
|
(12)
|
(8)
|
4
|
(1)
|
2
|
6
|
14
|
11
|
13
|
6
|
3
|
7
|
6
|
8
|
2
|
4
|
7
|
7
|
|
| Net Change in Cash |
51
N/A
|
130
+157%
|
347
+166%
|
415
+20%
|
185
-55%
|
286
+54%
|
(214)
N/A
|
(112)
+48%
|
(134)
-20%
|
(130)
+4%
|
(6)
+95%
|
(53)
-745%
|
370
N/A
|
316
-15%
|
819
+159%
|
665
-19%
|
309
-54%
|
312
+1%
|
(181)
N/A
|
(18)
+90%
|
64
N/A
|
(453)
N/A
|
(217)
+52%
|
(165)
+24%
|
(217)
-32%
|
107
N/A
|
|
| Free Cash Flow | |||||||||||||||||||||||||||
| Free Cash Flow |
(85)
N/A
|
(21)
+76%
|
(28)
-38%
|
(38)
-35%
|
(32)
+16%
|
(50)
-57%
|
(200)
-300%
|
(439)
-120%
|
(656)
-49%
|
(766)
-17%
|
(734)
+4%
|
(821)
-12%
|
(665)
+19%
|
(533)
+20%
|
(415)
+22%
|
(176)
+58%
|
(161)
+8%
|
(185)
-15%
|
(209)
-13%
|
(48)
+77%
|
(77)
-60%
|
(139)
-80%
|
(12)
+92%
|
(156)
-1 241%
|
(185)
-18%
|
(145)
+22%
|
|